<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142858">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01823484</url>
  </required_header>
  <id_info>
    <org_study_id>112233</org_study_id>
    <nct_id>NCT01823484</nct_id>
  </id_info>
  <brief_title>Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill</brief_title>
  <official_title>Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongda Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongda Hospital</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compared with AN69 hemofilter, AN69 ST hemofilter may prolong the time of hemofilter and
      decrease the quantity of heparin during continuous renal replacement therapy in critically
      ill.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2012</start_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The using time of hemofilters</measure>
    <time_frame>72h</time_frame>
    <safety_issue>No</safety_issue>
    <description>The time from the beginning of continuous renal replacement therapy until to the end when continuous renal replacement therapy had to be finished because of clotting or other reasons</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>activated partial thromboplastin time</measure>
    <time_frame>every 6h from the begining of continuous renal replacement therapy,up to 72h</time_frame>
    <safety_issue>No</safety_issue>
    <description>Heparin will be used according to activated partial thromboplastin time, and the quantity will be recorded.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of participants with adverse events during  continuous renal replacement therapy</measure>
    <time_frame>72h</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Critically Ill</condition>
  <condition>Acute Kidney Injury</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>AN 69 ST hemofilter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use AN 69 ST hemofilter during CRRT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AN 69 hemofilter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use AN 69 hemofilter during CRRT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AN 69 ST hemofilter</intervention_name>
    <arm_group_label>AN 69 ST hemofilter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AN 69 hemofilter</intervention_name>
    <arm_group_label>AN 69 hemofilter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt; 18 years old

          -  admitted to ICU and need CRRT

          -  anticipated survival time &gt;72h

        Exclusion Criteria:

          -  allergy to hemofilter or heparin

          -  heparin associated thrombocytopenia

          -  pregnancy or lactation

          -  using other anticoagulate drugs
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Qiu Xiaohua</last_name>
    <phone>02583262553</phone>
    <email>xiaohua0917@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xiaohua Qiu</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiu Xiaohua</last_name>
      <phone>02583262553</phone>
      <email>xiaohua0917@163.com</email>
    </contact>
    <investigator>
      <last_name>Qiu Xiaohua</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 13, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zhongda Hospital</investigator_affiliation>
    <investigator_full_name>Xiaohua Qiu</investigator_full_name>
    <investigator_title>physician</investigator_title>
  </responsible_party>
  <keyword>hemofilter</keyword>
  <keyword>coagulation</keyword>
  <keyword>CRRT</keyword>
  <keyword>critically ill</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
